On June 1, 2023 FibroBiologics, a clinical-stage company focused on the development of fibroblast cell-based therapeutics for chronic diseases, reported that Pete O’Heeron, Founder and Chief Executive Officer, will present a corporate overview next week at the 2023 BIO International Convention in Boston (Press release, FibroBiologics, JUN 1, 2023, https://fibrobiologics.com/fibrobiologics-to-present-corporate-update-at-2023-bio-international-convention/ [SID1234632341]). The presentation is set for 11:30 a.m. EDT on Tuesday, June 6, in Session Room 104A at the Boston Convention & Exhibition Center.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"We will highlight our recent progress in developing next-generation fibroblast cell-based therapies in multiple indications," said O’Heeron. "This is an exciting time for the company, and we look forward to connecting in person with members of the life sciences business community at the BIO conference. This is the industry’s largest and most prestigious event and we appreciate BIO’s selection of FibroBiologics as a presenting company that will be featured in the partnering section of the conference."

To schedule a meeting at the BIO International Convention with FibroBiologics, please submit a meeting request through the BIO One-on-One Partnering platform. For more information, please visit FibroBiologics’ website or send an e-mail to FibroBiologics at [email protected].